Additional file 1 of Efficacy and safety of selective JAK 1 inhibitor filgotinib in active rheumatoid arthritis patients with inadequate response to methotrexate: comparative study with filgotinib and tocilizumab examined by clinical index as well as musculoskeletal ultrasound assessment (TRANSFORM study): study protocol for a randomized, open-label, parallel-group, multicenter, and non-inferiority clinical trial

Authors :: Shimizu, Toshimasa
Kawashiri, Shin-ya
Morimoto, Shimpei
Kawazoe, Yurika
Kuroda, Shohei
Kawasaki, Rina
Ito, Yasuko
Kiya, Rieko
Sato, Shuntaro
Yamamoto, Hiroshi
Kawakami, Atsushi
Publication Year :: 2023
Publisher :: figshare, 2023.
Abstract: Additional file 1. SPIRIT 2013 Checklist.

Full Text Access

Tools